Antibody response against SARS-CoV-2 spike protein and nucleoprotein evaluated by four automated immunoassays and three ELISAs J Van Elslande, B Decru, S Jonckheere, E Van Wijngaerden, E Houben, ... Clinical Microbiology and Infection 26 (11), 1557. e1-1557. e7, 2020 | 153 | 2020 |
IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in healthcare workers B Decru, J Van Elslande, S Steels, G Van Pottelbergh, L Godderis, ... Frontiers in Immunology 13, 909910, 2022 | 29 | 2022 |
The metabolic fingerprint of COVID-19 severity T Dierckx, J Van Elslande, H Salmela, B Decru, E Wauters, J Gunst, ... MedRxiv, 2020.11. 09.20228221, 2020 | 17 | 2020 |
Comparison of the diagnostic performance with whole blood and plasma of four rapid antibody tests for SARS-CoV-2 B Decru, J Van Elslande, M Weemaes, E Houben, I Empsen, E André, ... Clinical Chemistry and Laboratory Medicine (CCLM) 58 (10), e197-e199, 2020 | 13 | 2020 |
Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction I Adant, M Bird, B Decru, P Windmolders, M Wallays, P de Witte, D Rymen, ... Molecular Metabolism 63, 101537, 2022 | 12 | 2022 |
No SARS‐CoV‐2 carriage observed in children attending daycare centers during the intial weeks of the epidemic in Belgium S Desmet, E Ekinci, I Wouters, B Decru, K Beuselinck, S Malhotra‐Kumar, ... Journal of Medical Virology 93 (3), 1828-1831, 2021 | 10 | 2021 |
No SARS-CoV-2 carriage observed in children attending daycare centers during the first weeks of the epidemic in Belgium S Desmet, E Ekinci, I Wouters, B Decru, K Beuselinck, S Malhotra-Kumar, ... medRxiv, 2020.05. 13.20095190, 2020 | 4 | 2020 |
Pseudohyperglycemia due to glucometer interference in galactosemia B Decru, H Blanckaert, G Naulaers, C Vanhole, D Rymen, P Witters, ... Clinical Chemistry and Laboratory Medicine (CCLM) 62 (5), e107-e109, 2024 | | 2024 |
Corrigendum: IgG anti-spike antibodies and surrogate neutralizing antibody levels decline faster 3 to 10 months after BNT162b2 vaccination than after SARS-CoV-2 infection in … B Decru, J Van Elslande, S Steels, G Van Pottelbergh, L Godderis, ... Frontiers in Immunology 13, 1098285, 2022 | | 2022 |